Naval Daver, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of immune checkpoint inhibitors for the treatment of acute myeloid leukemia (AML). Dr Daver highlights different trials evaluating immune checkpoint inhibitors as well as emerging immune checkpoint pathways. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).